TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial–mesenchymal transition and cancer stem cell phenotypes
Authors:
- 1 April 2015
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 359 (2) , 288-298
Abstract
No abstract availableKeywords
Funding Information
- Chongqing Medical Science Foundation (2011-1-055)
- National Natural Science Foundation of China (81101827)
- Chongqing Municipal Education Commission (KJ1400214)
- Yuzhong District of Chongqing (20140102)
This publication has 52 references indexed in Scilit:
- PRMT7 Induces Epithelial-to-Mesenchymal Transition and Promotes Metastasis in Breast CancerCancer Research, 2014
- Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transitionCancer Letters, 2014
- CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasisMolecular Cancer, 2014
- TGF-β in Epithelial to Mesenchymal Transition and Metastasis of Liver CarcinomaCurrent Pharmaceutical Design, 2012
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Metastasis: from dissemination to organ-specific colonizationNature Reviews Cancer, 2009
- Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traitsNature Reviews Cancer, 2009
- Epithelial–mesenchymal transition and the invasive potential of tumorsTrends in Molecular Medicine, 2008
- Cancer Metastasis: Building a FrameworkCell, 2006
- The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisitedNature Reviews Cancer, 2003